Top

Published in:

01-02-2017 | Environment and Autoimmunity

Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice

Authors: Shaye Kivity, Maria-Teresa Arango, Nicolás Molano-González, Miri Blank, Yehuda Shoenfeld

Published in: Immunologic Research | Issue 1/2017

Abstract

Human papillomavirus vaccine (HPVv) is used worldwide for prevention of infection. However several reports link this vaccine, with immune-mediated reactions, especially with neurological manifestations. Our previous results showed that HPVv-Gardasil and aluminum-immunized mice developed behavioral impairments. Studies have shown a positive effect of phospholipid supplementation on depression and cognitive functions in mice. Therefore, our goal was to evaluate the effect of a dietary supplement on vaccine-induced depression. Sixty C57BL/6 female mice were immunized with HPVv-Gardasil, aluminum or the vehicle (n = 20 each group), and half of each group were fed 5 times per week with 0.2 ml of a dietary supplement enriched with phosphatidylcholine. The mice were evaluated for depression at 3 months of age, by the forced swimming test. Both the Gardasil and the aluminum-treated mice developed depressive-like behavior when compared to the control group. The HPVv-Gardasil-immunized mice supplemented with phosphatidylcholine significantly reduced their depressive symptoms. This study confirms our previous studies demonstrating depressive-like behavior in mice vaccinated with HPVv-Gardasil. In addition, it demonstrates the ability of phosphatidylcholine-enriched diet to attenuate depressive-like behavior in the HPVv-Gardasil-vaccinated mice. We suggest that phosphatidylcholine supplementation may serve as a treatment for patients suffering vaccine-related neurological manifestations.

Kash N, et al. Safety and Efficacy data on vaccines and immunization to human papillomavirus. J Clin Med. 2015;4(4):614–33. doi:10.3390/jcm4040614.PubMedPubMedCentralCrossRef

McCormack PL, Joura EA. Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil(R)): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in women. Drugs. 2010;70(18):2449–74. doi:10.2165/11204920-000000000-00000.PubMedCrossRef

McCormack PL. Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (gardasil((R))): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts. Drugs. 2014;74(11):1253–83. doi:10.1007/s40265-014-0255-z.PubMedCrossRef

Gatto M, et al. Human papillomavirus vaccine and systemic lupus erythematosus. Clin Rheumatol. 2013;32(9):1301–7. doi:10.1007/s10067-013-2266-7.PubMedCrossRef

Geier DA, Geier MR. A case-control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events. Clin Rheumatol. 2015;34(7):1225–31. doi:10.1007/s10067-014-2846-1.PubMedCrossRef

Inbar R, et al. Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil. Immunol Res. 2016. doi:10.1007/s12026-016-8826-6.PubMed

Pellegrino P, et al. On the relationship between human papilloma virus vaccine and autoimmune diseases. Autoimmun Rev. 2014;13(7):736–41. doi:10.1016/j.autrev.2014.01.054.PubMedCrossRef

Tomljenovic L, Shaw CA. Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds? Ann Med. 2013;45(2):182–93. doi:10.3109/07853890.2011.645353.PubMedCrossRef

Kanduc D. Potential cross-reactivity between HPV16 L1 protein and sudden death-associated antigens. J Exp Ther Oncol. 2011;9(2):159–65.PubMed

10.

Kanduc D. Quantifying the possible cross-reactivity risk of an HPV16 vaccine. J Exp Ther Oncol. 2009;8(1):65–76.PubMed

11.

Li Z, Vance DE. Phosphatidylcholine and choline homeostasis. J Lipid Res. 2008;49(6):1187–94. doi:10.1194/jlr.R700019-JLR200.PubMedCrossRef

12.

Tayebati SK, Amenta F. Choline-containing phospholipids: relevance to brain functional pathways. Clin Chem Lab Med. 2013;51(3):513–21. doi:10.1515/cclm-2012-0559.PubMedCrossRef

13.

Kim HY, et al. Phosphatidylserine in the brain: metabolism and function. Prog Lipid Res. 2014;56:1–18. doi:10.1016/j.plipres.2014.06.002.PubMedCrossRef

14.

Vickers MH, et al. Supplementation with a mixture of complex lipids derived from milk to growing rats results in improvements in parameters related to growth and cognition. Nutr Res. 2009;29(6):426–35. doi:10.1016/j.nutres.2009.06.001.PubMedCrossRef

15.

Rondanelli M, et al. Long chain omega 3 polyunsaturated fatty acids supplementation in the treatment of elderly depression: effects on depressive symptoms, on phospholipids fatty acids profile and on health-related quality of life. J Nutr Health Aging. 2011;15(1):37–44.PubMedCrossRef

16.

Rondanelli M, et al. Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial. J Am Coll Nutr. 2010;29(1):55–64.PubMedCrossRef

17.

Benton D, et al. The influence of phosphatidylserine supplementation on mood and heart rate when faced with an acute stressor. Nutr Neurosci. 2001;4(3):169–78.PubMedCrossRef

18.

Katzav A, et al. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum. 2007;56(3):938–48. doi:10.1002/art.22419.PubMedCrossRef

19.

Porsolt RD, et al. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther. 1997;229:327–36.

20.

Katzav A, et al. Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS -SLE (depression). J Autoimmun. 2008;31(4):393–8. doi:10.1016/j.jaut.2008.09.002.PubMedCrossRef

21.

De Rosario-Martinez H, et al. Post-Hoc interaction Analysis—package ‘phia’. 0.2-1 ed2015. 2015. https://cran.r-project.org/web/packages/phia/phia.pdf

22.

Alijotas-Reig J. Human adjuvant-related syndrome or autoimmune/inflammatory syndrome induced by adjuvants. Where have we come from? Where are we going? A proposal for new diagnostic criteria. Lupus. 2015;24(10):1012–8. doi:10.1177/0961203315579092.PubMedCrossRef

23.

Karussis D, Petrou P. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmun Rev. 2013;13(3):215–24. doi:10.1016/j.autrev.2013.10.003.CrossRef

24.

Narcolepsy AS, et al. A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. J Autoimmun. 2009;50:1–11. doi:10.1016/j.jaut.2014.01.033.

25.

McCarthy JE, Filiano J. Opsoclonus Myoclonus after human papilloma virus vaccine in a pediatric patient. Parkinsonism Relat Disord. 2009;15(10):792–4. doi:10.1016/j.parkreldis.2009.04.002.PubMedCrossRef

26.

Colafrancesco S, et al. HPV vaccines and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Am J Reprod Immunol. 2013;70(4):309–16.PubMedCrossRef

27.

Shaw CA, Petrik MS. Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration. J Inorg Biochem. 2009;103(11):1555–62. doi:10.1016/j.jinorgbio.2009.05.019.PubMedPubMedCentralCrossRef

28.

Rogers MA, Simon DG. A preliminary study of dietary aluminium intake and risk of Alzheimer’s disease. Age Aging. 1999;28(2):205–9.CrossRef

29.

Bishop NJ, et al. Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. N Engl J Med. 1997;336(22):1557–61. doi:10.1056/NEJM199705293362203.PubMedCrossRef

30.

Walton JR. Evidence that ingested aluminum additives contained in processed foods and alum-treated drinking water are a major risk factor for Alzheimer’s disease. Curr Inorg Chem. 2012;2(1):19–39.CrossRef

31.

Rondeau V, et al. Relation between aluminum concentrations in drinking water and Alzheimer’s disease: an 8-year follow-up study. Am J Epidemiol. 2000;152(1):59–66.PubMedPubMedCentralCrossRef

32.

ATSDR. Toxicological profile for aluminum. Atlanta: Agency for toxic substances and disease registry; 2008.

33.

Tomljenovic L. Aluminum and Alzheimer’s disease: after a century of controversy, is there a plausible link? J Alzheimers Dis. 2011;23(4):567–98. doi:10.3233/Jad-2010-101494.PubMed

34.

Perl DP, Moalem S. Aluminum, Alzheimer’s disease and the geospatial occurrence of similar disorders. Rev Mineral Geochem. 2006;64:115–34.CrossRef

35.

Authier FJ, et al. Central nervous system disease in patients with macrophagic myofasciitis. Brain. 2001;124(Pt 5):974–83.PubMedCrossRef

36.

Exley C, et al. Elevated urinary excretion of aluminium and iron in multiple sclerosis. Mult Scler. 2006;12(5):533–40.PubMedCrossRef

37.

Melendez L, et al. Aluminium and other metals may pose a risk to children with autism spectrum disorder: biochemical and behavioural impairments. Clin Exp Pharmacol. 2013;3(1):120. doi:10.4172/2161-1459.1000120.CrossRef

38.

Tomljenovic L, Shaw CA. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? J Inorg Biochem. 2011;105(11):1489–99. doi:10.1016/j.jinorgbio.2011.08.008.PubMedCrossRef

39.

Seneff S, et al. Empirical data confirm autism symptoms related to aluminum and acetaminophen exposure. Entropy. 2012;14:2227–53.CrossRef

40.

Redhead K, et al. Aluminium-adjuvanted vaccines transiently increase aluminium levels in murine brain tissue. Pharmacol Toxicol. 1992;70(4):278–80.PubMedCrossRef

41.

Khan Z, et al. Slow CCL2-dependent translocation of biopersistent particles from muscle to brain. BMC Med. 2013;11:99. doi:10.1186/1741-7015-11-99.PubMedPubMedCentralCrossRef

42.

Lujan L, et al. Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA syndrome) in commercial sheep. Immunol Res. 2013;56(2–3):317–24. doi:10.1007/s12026-013-8404-0.PubMedCrossRef

43.

Vasudevaraju P, et al. Molecular toxicity of aluminium in relation to neurodegeneration. Indian J Med Res. 2008;128(4):545–56.PubMed

44.

Obulesu M, Rao DM. Animal models of Alzheimer’s disease: an understanding of pathology and therapeutic avenues. Int J Neurosci. 2010;120(8):531–7. doi:10.3109/00207451003760080.PubMedCrossRef

45.

Kumar V, et al. Impairment of mitochondrial energy metabolism in different regions of rat brain following chronic exposure to aluminium. Brain Res. 2008;1232:94–103. doi:10.1016/j.brainres.2008.07.028.PubMedCrossRef

46.

Agarwal SK, et al. Evaluation of the developmental neuroendocrine and reproductive toxicology of aluminium. Food Chem Toxicol. 1996;34(1):49–53. doi:10.1016/0278-6915(95)00088-7.PubMedCrossRef

47.

Singla N, Dhawan DK. Regulatory role of zinc during aluminium-induced altered carbohydrate metabolism in rat brain. J Neurosci Res. 2012;90(3):698–705. doi:10.1002/jnr.22790.PubMedCrossRef

48.

Walton JR. Aluminum Disruption of calcium homeostasis and signal transduction resembles change that occurs in aging and Alzheimer’s disease. J Alzheimers Dis. 2012;29(2):255–73. doi:10.3233/JAD-2011-111712.PubMed

49.

Shafer TJ, et al. Mechanisms underlying AlCl₃ inhibition of agonist-stimulated inositol phosphate accumulation. Role of calcium, G-proteins, phospholipase C and protein kinase C. Biochem Pharmacol. 1994;47(8):1417–25. doi:10.1016/0006-2952(94)90342-5.PubMedCrossRef

50.

Agmon-Levin N, et al. Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model. J Autoimmun. 2014;54:21–32. doi:10.1016/j.jaut.2014.06.006.PubMedCrossRef

51.

Kullenberg D, et al. Health effects of dietary phospholipids. Lipids Health Dis. 2012;11:3. doi:10.1186/1476-511X-11-3.PubMedPubMedCentralCrossRef

52.

Yechiel E, Barenholz Y. Relationships between membrane lipid composition and biological properties of rat myocytes. Effects of aging and manipulation of lipid composition. J Biol Chem. 1985;260(16):9123–31.PubMed

53.

Nicolson GL, Ash ME. Lipid replacement therapy: a natural medicine approach to replacing damaged lipids in cellular membranes and organelles and restoring function. Biochim Biophys Acta. 1838;6:1657–79. doi:10.1016/j.bbamem.2013.11.010.

54.

Borella E, et al. Lipid replacement therapy: is it a new approach in patients with chronic fatigue syndrome? J Autoimmune Dis Rheumatol. 2014;2:28–34.CrossRef

55.

Corwin J, et al. Behavioral effects of phosphatidylserine in the aged Fischer 344 rat: amelioration of passive avoidance deficits without changes in psychomotor task performance. Neurobiol Aging. 1985;6(1):11–5.PubMedCrossRef

56.

Park HJ, et al. Enhanced learning and memory of normal young rats by repeated oral administration of Krill Phosphatidylserine. Nutr Neurosci. 2013;16(2):47–53. doi:10.1179/1476830512Y.0000000029.PubMedCrossRef

57.

Kanno T, et al. DL-/PO-phosphatidylcholine restores restraint stress-induced depression-related behaviors and spatial memory impairment. Behav Pharmacol. 2014;25(5–6):575–81. doi:10.1097/FBP.0000000000000063.PubMed

58.

Baumeister J, et al. Influence of phosphatidylserine on cognitive performance and cortical activity after induced stress. Nutr Neurosci. 2008;11(3):103–10. doi:10.1179/147683008X301478.PubMedCrossRef

59.

Vakhapova V, et al. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement Geriatr Cogn Disord. 2010;29(5):467–74. doi:10.1159/000310330.PubMedCrossRef

60.

Kato-Kataoka A, et al. Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints. J Clin Biochem Nutr. 2010;47(3):246–55. doi:10.3164/jcbn.10-62.PubMedPubMedCentralCrossRef

61.

Manuel Y Keenoy B, et al. Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome. Life Sci. 2001;68(17):2037–49.PubMedCrossRef

62.

Pall ML. Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome. Med Hypotheses. 2000;54(1):115–25. doi:10.1054/mehy.1998.0825.PubMedCrossRef

63.

Richards RS, et al. Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. Redox Rep. 2000;5(1):35–41. doi:10.1179/rer.2000.5.1.35.PubMedCrossRef

64.

Tayebati SK, Amenta F. Choline-containing phospholipids: relevance to brain functional pathways. Clin Chem Lab Med. 2013;51(3):513–21. doi:10.1515/cclm-2012-0559.PubMedCrossRef

65.

Delwaide PJ, et al. Double-blind randomized controlled study of phosphatidylserine in senile demented patients. Acta Neurol Scand. 1986;73(2):136–40.PubMedCrossRef

66.

Glade MJ, Smith K. Phosphatidylserine and the human brain. Nutrition. 2015;31(6):781–6. doi:10.1016/j.nut.2014.10.014.PubMedCrossRef

67.

Oliveira TG, et al. The impact of chronic stress on the rat brain lipidome. Mol Psychiatry. 2016;21(1):80–8. doi:10.1038/mp.2015.14.PubMedCrossRef

68.

Leon A, et al. Effect of brain cortex phospholipids on adenylate-cyclase activity of mouse brain. J Neurochem. 1978;30(1):23–6.PubMedCrossRef

69.

Casamenti F, et al. Effect of phosphatidylserine on acetylcholine output from the cerebral cortex of the rat. J Neurochem. 1979;32(2):529–33.PubMedCrossRef

70.

Casamenti F, et al. Phosphatidylserine reverses the age-dependent decrease in cortical acetylcholine release: a microdialysis study. Eur J Pharmacol. 1991;194(1):11–6.PubMedCrossRef

71.

Ali HA, et al. Quercetin and omega 3 ameliorate oxidative stress induced by aluminium chloride in the brain. J Mol Neurosci. 2014;53(4):654–60. doi:10.1007/s12031-014-0232-8.PubMedCrossRef

72.

Nicolson GL, Conklin KA. Reversing mitochondrial dysfunction, fatigue and the adverse effects of chemotherapy of metastatic disease by molecular replacement therapy. Clin Exp Metastasis. 2008;25(2):161–9. doi:10.1007/s10585-007-9129-z.PubMedCrossRef

Title: Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice
Authors: Shaye Kivity
Maria-Teresa Arango
Nicolás Molano-González
Miri Blank
Yehuda Shoenfeld
Publication date: 01-02-2017
Publisher: Springer US
Published in: Immunologic Research / Issue 1/2017
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI: https://doi.org/10.1007/s12026-016-8818-6

At a glance: The STEP trials

Springer Medicine

Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2017

Clinicopathologic correlation of 282 leukocytoclastic vasculitis cases in a tertiary hospital: a focus on direct immunofluorescence findings at the blood vessel wall

Postural tachycardia syndrome (POTS) with anti-NMDA receptor antibodies after human papillomavirus vaccination

Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil

Elevated ferritin and circulating osteoprotegerin levels as independent predictors of hip fracture in postmenopausal women admitted for fragility fracture: time for new screening strategies?

Is the immune neuroendocrine system the connection between epipharyngitis and chronic fatigue syndrome induced by HPV vaccine?

Irregular antibodies in no hemolytic autoimmune diseases are able to induce erythrophagocytosis